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ABSTRACT 
Objective: The popularity of Sildenafil, the widespread distribution of various products and dietary supplements with added synthetic drugs, 
requires reliable analysis methods. This research study aimed to develop a simple isocratic HPLC method for the determination of Sildenafil in 
tablet dosage forms from the local market. 
Methods: Separation was carried out at 30 °C, using column LiChrosorb® RP-18 (150 x 4.0 mm, 5 μm) with mobile phase consisting of acetonitrile: 
methanol: 0.5% triethylamine (15: 26: 59 v/v/v). The detector was set at 290 nm. The flow rate was 1.0 ml/min and the injection volume was 20 μl. 
Results: Linear correlation was obtained within the range 6.25–50.0 μg/ml with correlation coefficient (R2) 0.9998. The achieved limits of detection 
and quantitation were 0.7 and 2.2 μg/ml, respectively. 
Conclusion: The developed method can be applied for the quality control of Sildenafil preparations. 
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Erectile dysfunction is a socially significant disorder. It can be 
caused by both various medical conditions [1] and psychogenic 
factors [2]. Most of erectile dysfunction treatment approaches are 
based on phosphodiesterase inhibitors [3]. Sildenafil citrate 
(chemically known as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-
1H-pyrazole [4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sulfonyl]-4-
methyl piperazine citrate) is a potent and selective phosphodiesterase 
inhibitor. It is the first phosphodiesterase inhibitor introduced on the 
market (Viagra®, Pfizer) [4].  
The social importance of erectile dysfunction, drug efficacy and easy 
internet access to Sildenafil (even without a prescription) can lead to 
unreasonable and uncontrolled use. Moreover, online drug purchases 
are always a risk, particularly in the case of illegal products that may 
contain poor-quality drugs or unknown analogs. This is especially 
dangerous for patients with preconditions for cardiovascular disease 
and/or concomitantly receiving cardiovascular drugs. On the other hand, 
healthy foods and dietary supplements have become increasingly 
popular in recent years. Many dietary supplements (advertised as 
"natural" or "herbal") are available on the market to help combat erectile 
dysfunction or improve sexual activity. Low control on such products 
makes it possible to insert medicines of unclear origin and quality, which 
in turn lead to health risks [5-8].  
The popularity of Sildenafil, the widespread distribution of various 
counterfeit products and dietary supplements with added synthetic 
drugs requires analysis methods for analysis. 
Various analytical techniques like spectrophotometry [9, 11], Raman 
spectroscopy [11, 12], thin layer chromatography [13], high 
performance liquid chromatography [14-23], high performance 
liquid chromatography-mass spectrometry [24-27] are reported for 
Sildenafil determination in pharmaceutical preparations [10, 12, 18-
20, 22, 23, 25], biological samples [16, 20, 21, 24-27], dietary 
supplements [3, 5, 13], herbal products [15] and drinks [11].  
Where the determination of traces or unknown analogs is necessary, 
then a highly sensitive technique, capable to provide information on the 
structure of the target substances is required. On the other hand, when a 
single substance is determined, conventional techniques are preferable 
due to their simplicity, accessibility, and relatively lower costs. 
This article presents the development of a simple isocratic HPLC 
method for the determination of Sildenafil in tablet dosage forms 
obtained randomly from the local market. 
The reagents used in this study were Sildenafil citrate (reference 
substance was obtained by Sigma Aldrich), HPLC grade acetonitrile, 
and methanol (Merck Ltd., Germany). Sildenafil tablets (50 mg) were 
obtained randomly from the local market. All other chemical 
reagents were of analytical grade.  
For the preparation of the reference solution, 25 mg (accurately 
weighed) of Sildenafil were dissolved with the mobile phase in a 
100.0 ml volumetric flask. Ten milliliters of this solution were 
diluted to 100.0 ml with the mobile phase (C = 25 μg/ml). 
For sample solution preparation, ten tablets of each formulation 
were weighed and were crushed to a fine powder. An amount 
equivalent to 50 mg Sildenafil (1 tablet) was weighed accurately and 
transferred in a 100.0 ml volumetric flask. Around 50 ml of the 
mobile phase were added and the mixture was sonicated for 10 min. 
Then the sample was diluted to 100.0 ml with the mobile phase. The 
solution was filtered and 5.00 ml were diluted to 100.0 ml with the 
mobile phase (C = 25 μg/ml). 
In this study, a high performance liquid chromatographic system 
(SHIMADZU Corporation) equipped with an LC-20 AD quaternary 
pump and autosampler, Shimadzu DGU-20A5 vacuum degasser, and 
a Shimadzu SPD-20A UV/VIS detector was used for analysis. To 
optimize the chromatographic conditions, some preliminary studies 
were conducted. 
In these studies, different stationary phases (C8 and C18) were used, 
as well as mobile phases with different compositions and ratios of 
the organic and aqueous phases. The combinations of acetonitrile: 
water and methanol: water in different ratios did not lead to 
satisfactory results. The effects of organic modifier (triethylamine, 
0.3-0.7%), flow rate, column temperature, and wavelength were also 
investigated. In the end, the optimal conditions achieved were as 
follows: C18 column (LiChrosorb® RP-18 (150 x 4.0 mm, 5 μm)), at 
30 °C and a mobile phase consisting of acetonitrile: methanol: 0.5% 
triethylamine (15: 26: 59 v/v/v). The detector was set at 290 nm. 
The flow rate was 1.0 ml/min and the injection volume was 20 μl. 
The mobile phase and the samples were filtered through a 0.45 μm 
membrane filter. The data was recorded using Lab Solutions 
Software. The retention time of Sildenafil was approximately 10 min 
and was comparable to the retention times from previously 
published reports [18, 23]. 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 13, Issue 1, 2021 
Bozhanov et al. 
Int J App Pharm, Vol 13, Issue 1, 2021, 253-256 
254 
The analytical method was validated according to the 
International Conference on Harmonization (ICH) guidelines 
[28]. 
The specificity of the HPLC method was determined by analyzing 
the standard drug solution and sample solution. As shown in fig. 1 
(standard solution) and fig. 2 (sample solution), there was no 
interference by the formulation excipients since no other peaks 
were corresponding to the retention time of the Sildenafil. 
The chromatographic parameters for Sildenafil, obtained at optimal 
experimental conditions, are listed in table 1. 
 
 
Fig. 1: Chromatogram of Sildenafil standard solution 
 
 
Fig. 2: Chromatogram of Sildenafil sample solution 
 
Table 1: Chromatographic data for the HPLC method 
Parameter Sildenafil 
Theoretical plates 2126±3.6 
Tailing factor 1.64±4.71x10-4 
Resolution factor 10.37±0.01 
Retention factor  6.92±0.01 
*The values are expressed as mean±SD, n=3 
 
Five standard solutions with concentrations within the range 6.25–
50.0 μg/ml were used for calibration and linearity study. Each 
solution was injected five times. The response (peak area) was 
plotted against the concentration of standard solutions. A linear 
correlation was obtained and the regression equation was y = 
126217.2x–29536.0 with correlation coefficient (R2) 0.9998. Limit of 
Detection (LOD) and Limit of Quantitation (LOQ) were evaluated 
based on signal-to-noise ratio and were found to be 0.7 and 2.2 
μg/ml, respectively, which are similar to earlier reported [16, 23].  
The precision was determined by six successive injections of a 
sample at the 100% concentration level of the Sildenafil. The RSD 
(%) values (table 2) for intra-and inter-day precision were found to 
be 0.16% and 0.65%, respectively, thus indicating that the method is 
precise. The method accuracy was evaluated by recovery studies. 
Samples at a concentration range of 50%-150% were prepared and 
each concentration level was injected in triplicate. The accuracy was 
expressed as the percentage of analyte recovered (>98%) and RSD 
(<1%). The results listed in table 3 show good accuracy and indicate 
that the proposed method is suitable for the quantitative 
determination of Sildenafil. 
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Table 2: Precision of the method 
Amount taken  
(mg/tablet) 
Intra-day Inter-day 
Amount found (mg/tablet) Amount found (%) Amount found (mg/tablet) Amount found (%) 
 
50.00 
50.09 100.2 50.15 100.3 
49.90 99.80 49.95 99.90 
49.96 99.92 49.86 99.72 
50.04 100.1 50.07 100.1 
49.89 99.78 49.79 99.58 
49.93 99.86 49.23 98.46 
Mean 49.97 99.94 49.84 99.68 
±SD 0.081 0.170 0.327 0.649 
RSD % 0.161 0.171 0.657 0.652 
*The values are expressed as mean±SD, n=6 
 
Table 3: Recovery studies of Sildenafil 
Level (%) Amount taken (mg) Amount found (mg) Amount found (%) ±SD RSD (%) 
50 25 24.96 99.84 0.048 0.194 
100 50 49.43 98.86 0.097 0.194 
150 75 74.96 99.95 0.121 0.161 
*The values are expressed as mean±SD, n=3 
 
The method was applied for the determination of Sildenafil in tablet 
dosage forms, randomly obtained from a local market. No significant 
differences were found between achieved results (table 4) and label 
claim.
  
Table 4: Determination of Sildenafil in tablet formulations 
Product  Amount declared (mg/tablet) Amount found (mg/tablet) Results (%) 
Product 1 50 50.08±0.022 100.2 
Product 2 50 49.56±0.036 99.12 
Product 3 50 49.83±0.046 99.66 
*The values are expressed as mean±SD, n=3 
 
CONCLUSION 
The isocratic HPLC-UV method, described in this paper, was 
developed for determination and quantity control of the Sildenafil in 
tablets. The procedure showed satisfactory run time (12 min), good 
linearity range (6.25–50.0 μg/ml), and a high degree of accuracy and 
precision (RSD<1%). The method is simple, easy for 
implementation, and requires common equipment; therefore, it is 
cost-effective. It was successfully applied to real samples. 
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